ATE390144T1 - Behandlung von fibrosen - Google Patents

Behandlung von fibrosen

Info

Publication number
ATE390144T1
ATE390144T1 AT04766732T AT04766732T ATE390144T1 AT E390144 T1 ATE390144 T1 AT E390144T1 AT 04766732 T AT04766732 T AT 04766732T AT 04766732 T AT04766732 T AT 04766732T AT E390144 T1 ATE390144 T1 AT E390144T1
Authority
AT
Austria
Prior art keywords
treatment
fibrosis
insp035
scleroderma
prevention
Prior art date
Application number
AT04766732T
Other languages
English (en)
Inventor
Christine Power
Yan Lavrovsky
Original Assignee
Serono Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Lab filed Critical Serono Lab
Application granted granted Critical
Publication of ATE390144T1 publication Critical patent/ATE390144T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04766732T 2003-09-08 2004-09-07 Behandlung von fibrosen ATE390144T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03102723 2003-09-08

Publications (1)

Publication Number Publication Date
ATE390144T1 true ATE390144T1 (de) 2008-04-15

Family

ID=34259208

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04766732T ATE390144T1 (de) 2003-09-08 2004-09-07 Behandlung von fibrosen

Country Status (10)

Country Link
US (1) US8283307B2 (de)
EP (1) EP1663294B1 (de)
JP (1) JP4723496B2 (de)
AT (1) ATE390144T1 (de)
AU (1) AU2004269927B2 (de)
CA (1) CA2535021A1 (de)
DE (1) DE602004012759T2 (de)
ES (1) ES2300817T3 (de)
IL (1) IL174134A0 (de)
WO (1) WO2005023288A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7878978B2 (en) 2004-03-18 2011-02-01 University Of Pittsburgh- Of The Commonwealth System Of Higher Education Use of relaxin to increase arterial compliance
US8747897B2 (en) * 2006-04-27 2014-06-10 Supernus Pharmaceuticals, Inc. Osmotic drug delivery system
JP6675605B2 (ja) * 2014-10-10 2020-04-01 国立大学法人高知大学 細胞遊走調節に関する疾患の予防・治療剤および肺間質の疾患の疾患活動性判定・予後評価

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
KR20000016402A (ko) 1996-06-06 2000-03-25 피터 기딩스 렙틴(ob단백질)의 프레그먼트
US6777388B1 (en) 1998-08-21 2004-08-17 Clf Medical Technology Acceleration Program, Inc. Leptin-related peptides
WO2001088088A2 (en) * 2000-05-18 2001-11-22 Hyseq, Inc. Novel nucleic acids and polypeptides
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
WO2002066071A2 (en) * 2001-01-03 2002-08-29 Thomas Jefferson University Treatment of tissue fibrosis by blocking the sp1 transcription factor
EP1368475A4 (de) 2001-03-15 2004-10-20 Nuvelo Inc Neue nukleinsäuren und polypeptide
US20040142325A1 (en) * 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
GB0130720D0 (en) * 2001-12-21 2002-02-06 Serono Internat S A Proteins
AU2003240754B2 (en) * 2002-04-10 2009-02-26 Merck Serono Sa Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis

Also Published As

Publication number Publication date
US20070104723A1 (en) 2007-05-10
AU2004269927B2 (en) 2009-09-17
IL174134A0 (en) 2006-08-01
JP2007505082A (ja) 2007-03-08
EP1663294A1 (de) 2006-06-07
WO2005023288A1 (en) 2005-03-17
ES2300817T3 (es) 2008-06-16
JP4723496B2 (ja) 2011-07-13
CA2535021A1 (en) 2005-03-17
WO2005023288A8 (en) 2005-05-19
EP1663294B1 (de) 2008-03-26
AU2004269927A1 (en) 2005-03-17
DE602004012759T2 (de) 2008-07-17
US8283307B2 (en) 2012-10-09
DE602004012759D1 (de) 2008-05-08

Similar Documents

Publication Publication Date Title
ATE433973T1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
NO20034056D0 (no) Proliferative sykdommer
ATE489957T1 (de) Mittel zur behandlung von entzündlichen erkrankungen
ATE376835T1 (de) Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis
ATE512163T1 (de) Verabreichung von mitteln zur behandlung von entzündungen
EA200401341A1 (ru) Применение остеопротегерина для лечения и/или профилактики фиброзного заболевания
EA200601553A1 (ru) Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды
EA200900802A1 (ru) Способы и композиции для лечения амилоидных заболеваний
EA200700175A1 (ru) Композиции и способы лечения воспалительных заболеваний
BR0309665A (pt) Tratamento de deficiência de alfa-galactosidase a
DK1556021T3 (da) Farmaceutiske sammensætninger omfattende flavonoider og menthol samt fremgangsmåder til behandling med brug af nævnte sammensætninger
UA85559C2 (en) Aminobenzophenone compounds
NO20055130L (no) Aminocykloheksyleter-forbindelser og deres anvendelse
NO20055741D0 (no) Nye kjemiske forbindelser
ATE549024T1 (de) Chinazolin-kaliumkanalhemmer
EA200501528A1 (ru) Применение кластерина для лечения и/или профилактики периферических неврологических заболеваний
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser
DE602004019541D1 (de) Cycloalkyläbü kondensierte indole
TR200200278T2 (tr) Kalsilitik bileşimler
BR0111785A (pt) Composições e métodos para tratamento de candidìase
ATE406171T1 (de) Aplidine zur behandlung von multiplem myelom
DE602004009414D1 (de) BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN MIT N-2,3,3-TETRAMETHYLBICYCLOi2.2.1öHEPTAN-2-AMINE
DE602004013011D1 (de) Haarbehandlungszusammensetzungen
UA85187C2 (en) 2-aminobenzoyl derivatives
DE602004012759D1 (de) Behandlung von fibrosen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties